rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    GCTK
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      GlucoTrack completes structured financing and reverse stock split

      Detailed price information for Glucotrack Inc (GCTK) from The Globe and Mail including charting and trades.

      Oct 23The Globe and MailGCTK
      Glucotrack implements 1-for-2 reverse stock split Monday
      Oct 22Investing.comGCTK
      Glucotrack, Inc. Announces Reverse Stock Split
      Oct 22Yahoo FinanceGCTK
      GlucoTrack Tightens Terms in Recent Financing Amendments

      Detailed price information for Glucotrack Inc (GCTK-Q) from The Globe and Mail including charting and trades.

      Sep 29The Globe and MailGCTK
      Glucotrack announces amendments to warrant and note agreements, repays bridge notes
      Sep 28Investing.comGCTK
      GlucoTrack Announces Debt-Reducing Public Equity Offering

      Detailed price information for Glucotrack Inc (GCTK-Q) from The Globe and Mail including charting and trades.

      Sep 25The Globe and MailGCTK
      Lōkahi Therapeutics™ Expands ai2 Pipeline™ Program Through Collaboration with Pepperdine E2B™
      Sep 25Yahoo FinanceGCTK
      What's Going On With GlucoTrack Shares On Thursday? - GlucoTrack (NASDAQ:GCTK)

      GlucoTrack subsidiary Lokahi Therapeutics secured its first external fee-for-service partnership with nonprofit Innovate GBM for glioblastoma research.

      Sep 24BenzingaGCTK
      Glucotrack prices $3.1 million public offering at $2.04/share
      Sep 24Investing.comGCTK
      Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
      Sep 24Yahoo FinanceGCTK
      12 Health Care Stocks Moving In Thursday's Pre-Market Session - Profusa (NASDAQ:PFSA), GlucoTrack (NASDAQ

      Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market session. The company's market cap stands at $1.2 million. GlucoTrack (NASDAQ:GCTK) stock rose 96.55% to $3.99. The

      Sep 24BenzingaGCTKSRZNSRZNW
      Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket - GlucoTrack

      GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership; other stocks saw notable gains and losses.

      Sep 24BenzingaGCTKTWG
      GlucoTrack Stock Surges 80% After Hours on Brain Tumor Deal - GlucoTrack (NASDAQ:GCTK)

      GlucoTrack shares soar 80% after-hours as Lokahi Therapeutics signs first external glioblastoma licensing partnership with Innovate GBM.

      Sep 24BenzingaGCTK
      12 Health Care Stocks Moving In Wednesday's After-Market Session - GlucoTrack (NASDAQ:GCTK), Greenland Mi

      Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after-market session. The market value of their outstanding shares is at $1.7 million. Greenland Mines (NASDAQ:GRML) shares

      Sep 23BenzingaBRTXGCTK
      Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities

      RUTHERFORD, N.J. & LA JOLLA, Calif., September 23, 2026--Lōkahi CEO Erik Emerson outlines LT-100 progress, ai² platform growth, and a strategy to discover, advance, and monetize assets.

      Sep 23Yahoo FinanceGCTK
      GlucoTrack Director Resigns Amid Merger Conflict Concerns

      Detailed price information for Glucotrack Inc (GCTK-Q) from The Globe and Mail including charting and trades.

      Sep 19The Globe and MailGCTK
      Glucotrack director Paul V. Goode resigns citing potential conflict of interest
      Sep 18Investing.comGCTK
      Glucotrack shareholders approve stock issuance proposals and amend warrant terms
      Sep 14Investing.comGCTK
      Glucotrack secures $11.5M in convertible note financing
      Sep 11Investing.comGCTK
      Glucotrack Announces $11.5 Million Financing

      RUTHERFORD, N.J. & LA JOLLA, Calif., September 11, 2026--Glucotrack announces $11.5M convertible note financing, including new capital and note rollover, to support strategic growth.

      Sep 11Yahoo FinanceGCTK
      GlucoTrack Settles Disputed Debt with Convertible Note

      Detailed price information for Glucotrack Inc (GCTK-Q) from The Globe and Mail including charting and trades.

      Sep 10The Globe and MailGCTK
      GlucoTrack Executes Reverse Stock Split to Restructure Shares

      Tipranks Press Release.

      Aug 29The Globe and MailGCTK
      GlucoTrack Announces 1-for-15 Reverse Stock Split

      Tipranks Press Release.

      Aug 28The Globe and MailGCTK
      Glucotrack to implement 1-for-15 reverse stock split Monday
      Aug 27Investing.comGCTK
      Glucotrack, Inc. Announces Reverse Stock Split

      RUTHERFORD, N.J. & LA JOLLA, Calif., August 27, 2026--Glucotrack (Nasdaq: GCTK) announced a 1-for-15 reverse stock split effective August 31, 2026, to support Nasdaq listing compliance.

      Aug 27Yahoo FinanceGCTK
      Lōkahi Therapeutics™ Initiates Clinical Trial Manufacturing for LT-100

      RUTHERFORD, N.J. & LA JOLLA, Calif., August 25, 2026--Lōkahi Therapeutics™ initiates GMP manufacturing of LT-100 and advances preparations for the program's next clinical milestone.

      Aug 25Yahoo FinanceGCTK

      This is the newest page. Registered accounts read further back.